Approved Study Database

Ref. No. Scientific Title Principal investigator
2025.636 A Multi-Country Observational Chart Review Study to Characterize Treatment Patterns and Clinical Outcomes among Patients with Resectable Gastric or Gastroesophageal Junction Cancer Prof. YEO Winnie
2025.635 Development of a risk evaluation model for bone scintigraphy triage based on machine learning and artificial intelligence and large language models. Dr. Wong Matthew Lun
2025.634 A territory-wide retrospective study comparing between transrectal versus transperineal prostate biopsy Dr. LIU Alex Qinyang
Chi Fai NG
2025.633 Long-term Outcomes of Prostatic Artery Embolization (PAE) – A retrospective cohort study Dr. CHIU Peter Ka Fung
2025.632 The prognostic impact of change in serum alpha-fetoprotein level for recurrent hepatocellular carcinoma after hepatectomy: a retrospective study Dr. LEE Kit Fai
2025.631 AI Screening of Head CT scans for Cognitive Decline Dr. Abrigo Jill
2025.630 Left Atrial Appendage Occlusion in Dialysis Patients with Atrial Fibrillation: A Multicentre Pilot Study Dr. SO Kent Chak Yu
2025.629 TulmiSTAR-02: A two-part Phase I dose escalation study of tulmimetostat (DZR123) in combination with darolutamide or abiraterone followed by open-label, randomized, Phase II dose expansion study to assess the safety and efficacy of tulmimetostat in combination with darolutamide versus darolutamide alone in patients with metastatic hormone-sensitive prostate cancer Prof. NG Chi Fai
2025.628 A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of GSK5764227 as Monotherapy and in Combination in Participants with Advanced Solid Tumors Dr. LOONG Herbert Ho Fung
2025.627 A Randomized, Phase 2/3 Study Comparing Navlimetostat (BMS-986504) in Combination with Nab-paclitaxel and Gemcitabine versus Placebo in Combination with Nab-paclitaxel and Gemcitabine in Participants with Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletion Prof. CHAN Stephen Lam
2025.626 A Randomized Phase 2/3 Study of BMS-986504 in Combination with Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants with Homozygous MTAP Deletion Dr. LI Siu Ching
2025.625 Smart Bracing for Adolescent Idiopathic Scoliosis: A Pilot Study of Real-Time Continuous Monitoring via Fiber Optic FBG Sensor Dr. LAU Adam Yiu Chung
2025.624 Quantitative measurement of plasma and urine MTB cell-free DNA level in diagnosing TB and treatment monitoring Prof. CHAN Ken Ka Pang
2025.623 Can Alpha-ketoglutarate (AKG) Ameliorate Sarcopenia? A Randomized, Double-Blind, Placebo-Controlled Trial Dr. LIU Chaoran
2025.622 Effect of an internet-based dialectical behaviour therapy-informed skills training for reducing alcohol consumption and improving psychological distress of adult drinkers: A randomised controlled trial Prof. Ho Long Kwan
2025.621 Novel microbiome signatures for the prediction of dementia-first versus parkinsonism-first conversion in REM sleep behavior disorder Dr. HUANG Bei
2025.620 A RETROSPECTIVE STUDY ON EFFICACY AND TOLERABILITY OF TRASTUZUMAB DERUXTECAN FOR ADVANCED BREAST CANCER PATIENTS WITH HER2-POSITIVE, HER2-LOW OR HER2-ULTRALOW DISEASE Prof. YEO Winnie
2025.619 Review of Clinical Outcomes of Structured Non-Surgical Treatment Programme for Knee Osteoarthritis in Prince of Wales Hospital Ms. Li Man Kuen
2025.618 Evaluation knowledge level of ACLS among HKFSD paramedics Mr. Wong Kwan Tung
黃鈞彤
2025.617 Effectiveness of a nurse-led WeChat-based multi-component intervention on body weight in colorectal cancer patients undergoing chemotherapy: a randomised controlled study Ms. CAO Yu
曹玉
2025.616 The Effects of Transcranial Temporal Interference Stimulation to the Amygdala on Emotion Regulation and Conflict Resolution Dr. LIU Xiaonan
2025.615 Telehealth-supported discharge programme on health outcomes among frail older adults: A pilot randomized controlled trial Prof. XIAO Sarah
2025.614 7-year prospective study of psychiatric patients with comorbid REM sleep behavior disorder: diagnostic stability and progression of prodromal features of α- synucleinopathy Prof. WING Yun Kwok
2025.613 Effects of Ten-Week Oral Nicotinamide Riboside Supplementation with Aerobic Exercises on Blood Pressure in Post-menopausal Women with Elevated/Stage I Hypertension Prof. Yu Angus Pak Hung
2025.612 A pilot experimental study of acoustic stimulation in enhancing slow wave sleep to improve sleep quality in insomnia disorder Dr CHEN XIE
陈勰
2025.611 AFFIRM: A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis Prof. Lai Jimmy Che To
2025.610 From Benchside to Clinical: Identifying the Probiotic to Treat Sarcopenia in Older Adults for Healthy Aging Prof. WONG Ronald Man Yeung
2025.609 A prospective randomised study to compare patient satisfaction following the treatment of lower caliceal stones using shockwave lithotripsy or retrograde intrarenal surgery Prof. NG Chi Fai
2025.608 Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant monotherapy compared with standard of care in patients with early-stage, resectable non-small cell lung cancer (Stage II-IIIB) harboring tyrosine kinase domain activating HER2 mutations Dr. LOONG Herbert Ho Fung
2025.607 Effectiveness of Haptik App Feedback on Apple Watch in improving Cardiopulmonary Resuscitation (CPR) Quality in Paramedics: A Randomized Crossover Trial Mr. CHAN CHI YIP
陳智業
2025.606 Natural History of Patients with Staghorn Stones in Hong Kong over 17 years: A Real-World Cross Sectional Observational Study Dr. LIU Qinyang
2025.605 A Phase I/II, Open-label, Multicenter Study of ALE.P03 (Claudin-1 Targeted Antibody-drug Conjugate) as a Monotherapy in Adult Patients with Selected Advanced or Metastatic CLDN1+ Solid Tumors Prof. CHAN Stephen Lam
2025.604 Clamp catheter versus snare for Inferior Vena Cava filter retrieval: a single centre experience Dr. LAW Wing Chung
2025.603 Cardio-Oncology in Prostate Cancer: Building a Territory-Wide Cohort with Risk Prediction and Target Trial Emulation framework for cardio-protective strategies Dr. Liu Qinyang
2025.602 Dynamic changes of serum albumin-to-globulin ratio predict major adverse cardiovascular events in prostate cancer patients undergoing androgen deprivation therapy Prof. NG Chi Fai
2025.601 An international multicenter registry study for young-onset colorectal cancer in East and Southeast Asia Prof. Ng Simon
2025.600 Predictive modelling of urological outcomes based on retrospective routine nurse-led clinic assessments Prof. LIU Qinyang
2025.599 Erectile dysfunction and major adverse cardiovascular events in prostate cancer Prof. NG Chi Fai
2025.598 Epidemiological Trend and Projections on Disease Burden in Hong Kong Prof. HUANG Junjie
2025.597 Construction of diagnostic and predictive models for cirrhosis patients with complications of liver disease Prof. Wong Grace
2025.596 Deciphering the role of ADAT2-mediated transfer RNA A-to-I modification in colorectal tumorigenesis and chemoresistance Dr. WONG Chi Chun
Chi Chun Wong
2025.595 The level of knowledge, attitude, and practice (KAP) to stroke management among undergraduate nursing students in Hong Kong: A cross-sectional survey Miss Lo Tsz Yau
盧芷柔
2025.594 Phase I Clinical Trial of Low and High Dose Allogeneic Mesenchymal Stromal Cell Treatment for Knee Osteoarthritis Prof. ONG Michael Tim Yun
王添欣
2025.593 Comparison of Vacuum Mattresses and Spinal Long Boards in Wilderness simulation Mr. CHING SZE YU
2025.592 Evaluation of airway management by first responders (fire personnel of the Hong Kong Fire Services Department) on out-of-hospital cardiac arrest patients in Hong Kong: a crossover study Mr. WU Ka yiu
2025.591 Safety and Feasibility of Custom Engineered Curved Scissors for Nasal Surgery Dr. YEUNG David
David Chun Man Yeung
2025.590 A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05) Prof. YEO Winnie
2025.589 A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab (MK-3475) Versus Treatment of Physician’s Choice (TPC) in Participants With Triple-Negative Breast Cancer (TNBC) Who Received Neoadjuvant Therapy and Did Not Achieve a Pathological Complete Response (pCR) at Surgery Prof. YEO Winnie
2025.588 Exploring the Protective Role of Bacteroides intestinalis against Metabolic Dysfunction-Associated Steatotic Liver Disease Prof. ZHANG Xiang
2025.587 Satisfaction, Visual and Refractive Outcomes of Bilateral Cataract Extraction with Implantation of Light Adjustable Intraocular Lenses (IOL) Prof. THAM Clement Chee Yung

Page 16 of 288.